DPP4 and inflammatory myofibroblastic tumor: Although the exact mechanism by which DPP-4 inhibitors induce the regression of carotid IMT remains uncertain at present, the differences in carotid IMT progression could not be explained by the difference in HbA1c as we discussed in the original article [8].